Эффективность микроимпульсной циклофотокоагуляции в лечении рефрактерной глаукомы

Abstract

Purpose. To evaluate the clinical efficacy of micropulse cyclophotocoagulation (mCPC) in the treatment of patients with grade III refractory glaucoma. Material and methods. A clinical analysis of the state of 30 eyes with grade III refractory glaucoma after mCPC was performed. Forms of glaucoma: multiple operated primary open-angle glaucoma – 22 eyes, neovascular glaucoma – 7 eyes, uveal glaucoma with neovascularization – 1 eye. The level of intraocular pressure (IOP) before surgery was 27–41 mm Hg, averaging 32.2 ± 3.8 mm Hg. The average number of antihypertensive drops before surgery was 2.6 ± 0.3 drugs. The observation period was 6 months. Results. All surgeries went without complications. The average level of IOP on the 1st postoperative day was 22.7 ± 2.1 mm Hg, in 93 % of cases IOP decreased to 18–24 mm Hg. After 1 week, the average level of IOP was 21.8 ± 1.7 mm Hg: in 93 % of cases it was 18–23 mm Hg, in 7 % the level of IOP remained elevated to 25–27 mm Hg. Art. By the 1st month after mCPC, the average IOP level decreased to 20.3 ± 2.2 mm Hg, after 3 months it was 20.8 ± 2.2 mm Hg. After 6 months, the level of IOP corresponded to 18–26 mm Hg. Art., averaging 21.6 ± 1.9 mm Hg. The number of antihypertensive drugs was reduced to an average of 1.7 ± 0.2. Conclusion. mCPC has been shown to be effective in normalizing IOP levels in the majority of patients with grade III refractory glaucoma (87 %) at 6 month follow-up. Keywords: refractory glaucoma, micropulse cyclophotocoagulation, intraocular pressure.